Company Data
AN2 Therapeutics Inc.
Ticker
ANTX
Current Price
$1.13
Market Cap
$33.8M
Price Target
Refer to Report
Volume
341.7K
52wk Range
$0.87 - $3.88
Overview
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.